Relation of hepatitis B core antigen expression with histological activity, serum HBeAg, and HBV DNA levels

Aysegul Sari1, Yelda Dere, Betul Pakoz

  • 1Department of Pathology, Izmir Ataturk Researh and Training Hospital, Izmir, Turkey. aysegulakder@gmail.com

Insights

Hepatitis B core antigen (HBcAg) expression is linked to liver disease progression in HBeAg-negative patients. Nuclear HBcAg and high HBV DNA levels indicate a higher risk for progressive liver disease in this group.

Area of Science:

  • Hepatology
  • Virology
  • Immunohistochemistry

Background:

  • Hepatitis B virus (HBV) infection can lead to severe liver conditions like cirrhosis and liver failure.
  • Intrahepatic viral antigen expression patterns may offer prognostic insights into HBV disease progression.

Purpose of the Study:

  • To examine the association between HBV core antigen (HBcAg) expression and histological activity index (HAI), fibrosis, hepatitis B e-antigen (HBeAg) status, and HBV DNA levels in chronic HBV patients.

Main Methods:

  • Analysis of 114 liver biopsies from patients with chronic HBV infection.
  • Immunohistochemical assessment of HBcAg expression.
  • Correlation analysis with HAI, fibrosis, ALT levels, HBeAg status, and HBV DNA levels.

Main Results:

  • Nuclear HBcAg expression did not correlate with ALT levels, HAI, or fibrosis.
  • Nuclear HBcAg expression was higher in HBeAg-positive patients.
  • In HBeAg-negative patients, nuclear HBcAg correlated with HBV DNA levels and fibrosis scores, unlike in HBeAg-positive patients. HBV DNA levels were also associated with HAI and fibrosis in HBeAg-negative patients.

Conclusions:

  • HBeAg-negative HBV disease differs significantly from HBeAg-positive disease.
  • Nuclear HBcAg expression and elevated HBV DNA levels in HBeAg-negative patients are indicators of increased risk for progressive liver disease.
Abstract